Latest filing: Dr Reddys Laboratories Ltd - 500124 - Announcement Under Regulation 30 Of SEBI (LODR) Regulation, 2015
ObservedCompany dossier
Dr Reddys Laboratories
NSE:DRREDDY · ISIN INE089A01031
- Close
- ₹1,142.3 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Dr Reddys Laboratories
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 30 Jun 2026 · revenue N/A · PAT N/A.
Exchange XBRLLatest ownership: promoter group 26.64% and public 73.16% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Dr Reddys Laboratories Ltd - 500124 - Announcement Under Regulation 30 Of SEBI (LODR) Regulation, 2015
BSE · exchange filing
Observed
Source filing General Updates - Dr. Reddy's Laboratories Limited
NSE · exchange filing
Observed
Source filing News Verification - Dr. Reddy's Laboratories Limited
NSE · exchange filing
Observed
Source filing Dr Reddys Laboratories Ltd - 500124 - Clarification-Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
BSE · exchange filing
Reported financials
Full financials →30 Jun 2026
- Revenue from operations
- N/A
- Profit after tax
- N/A
- EPS
- N/A
Observed BSE structured filing · consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 26.64%
- Public
- 73.16%
- Employee trust
- 0.20%
Observed NSE shareholding XBRL